Personalized Medicine Coalition Proposes Policies For Next Iteration Of Genomics And Personalized Medicine Act
The Personalized Medicine Coalition is circulating policy concepts aimed to spur growth in the personalized medicine arena, with hopes of seeing them incorporated into future legislation.
You may also be interested in...
Supported by robust data demonstrating knock-out response rates, Roche/Genentech’s Zelboraf (vemurafenib) has sailed through the FDA approval process, aided by a push from the agency.
Biotech trade group says it is still developing its positions, but hopes to move legislation this year that addresses diagnostics reimbursement.
Food safety programs would get the largest increase in the White House’s proposed fiscal 2015 FDA budget, and increases in user fee programs are proposed as key drivers for the boost. The agency’s overall budget would grow $335 million to $4.7 billion in the proposal.